Stephens Kristin
SEC insider (Form 3/4/5 filer). CIK 0001865490. Chief Development Officer at Syros Pharmaceuticals, Inc. (SYRS). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 18, 2024. Located in CAMBRIDGE, MA.
Companies Stephens Kristin has filed insider reports for
- Syros Pharmaceuticals, Inc. (SYRS): Officer, Chief Development Officer
Stephens Kristin
CIK: 0001865490
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SYRS
Syros Pharmaceuticals, Inc.
Officer